EMG
INO icon

Ellington Management Group’s Inovio Pharmaceuticals INO Stock Holding History

Ellington Management Group’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,442
Closed -$308K – 654
2018
Q1 		$308K Buy
+5,442
New +$295K 0.02% 581
2017
Q4 		– Sell
-2,342
Closed -$178K – 693
2017
Q3 		$178K Buy
2,342
+492
+27% +$36.6K 0.03% 543
2017
Q2 		$174K Buy
+1,850
New +$158K 0.03% 555
2016
Q1 		– Sell
-2,230
Closed -$180K – 592
2015
Q4 		$180K Buy
+2,230
New +$178K 0.06% 487

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ellington Management Group's INO Position: Q2 2018 in Review

Ellington Management Group sold out of Inovio Pharmaceuticals (INO) in Q2 2018, closing a stake of 5,442 shares — an estimated $308K sold.

Ellington Management Group first reported a position in INO in Q4 2015 and held it in 4 quarters. The position peaked at $308K in Q1 2018. 126 funds tracked by Wall St. Rank hold INO as of Q2 2018.

  • Ellington Management Group reported no remaining Inovio Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Ellington Management Group sold 5,442 Inovio Pharmaceuticals shares in Q2 2018, an estimated $308K.
  • Ellington Management Group first reported a position in Inovio Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • Ellington Management Group's Inovio Pharmaceuticals position peaked at $308K in Q1 2018.
  • 126 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2018.

Based on Ellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.